Evaluation of the performance of 25 SARS-CoV-2 serological rapid diagnostic tests using a reference panel of plasma specimens at the Uganda Virus Research Institute

Introduction: Serological testing is needed to better understand the epidemiology of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus. Rapid diagnostic tests (RDTs) have been developed to detect specific antibodies, IgM and IgG, to the virus. The performance of 25 of these RDTs...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Tom Lutalo, Aminah Nalumansi, Denis Olara, John Kayiwa, Bernard Ogwang, Emmanuel Odwilo, Christine Watera, Stephen Balinandi, Jocelyn Kiconco, Joweria Nakaseegu, Jennifer Serwanga, Bernard Kikaire, Deogratius Ssemwanga, Brendah Abiko, Christopher Nsereko, Matthew Cotten, Joshua Buule, Julius Lutwama, Robert Downing, Pontiano Kaleebu
Formato:	article
Lenguaje:	EN
Publicado:	Elsevier 2021
Materias:	COVID-19 SARS-CoV-2 Rapid diagnostic test antibody serological reference panel performance Infectious and parasitic diseases RC109-216
Acceso en línea:	https://doaj.org/article/0b0beca23d9d43df8d2c2299dac6f1d8
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:0b0beca23d9d43df8d2c2299dac6f1d8
record_format	dspace
spelling	oai:doaj.org-article:0b0beca23d9d43df8d2c2299dac6f1d82021-11-30T04:14:13ZEvaluation of the performance of 25 SARS-CoV-2 serological rapid diagnostic tests using a reference panel of plasma specimens at the Uganda Virus Research Institute1201-971210.1016/j.ijid.2021.09.020https://doaj.org/article/0b0beca23d9d43df8d2c2299dac6f1d82021-11-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S1201971221007281https://doaj.org/toc/1201-9712Introduction: Serological testing is needed to better understand the epidemiology of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus. Rapid diagnostic tests (RDTs) have been developed to detect specific antibodies, IgM and IgG, to the virus. The performance of 25 of these RDTs was evaluated. Methods: A serological reference panel of 50 positive and 100 negative plasma specimens was developed from SARS-CoV-2 PCR and antibody positive patients and pre-pandemic SARS-CoV-2-negative specimens collected in 2016. Test performance of the 25 RDTs was evaluated against this panel. Results: A total of 10 RDTs had a sensitivity ≥98%, while 13 RDTs had a specificity ≥98% to anti-SARS-CoV-2 IgG antibodies. Four RDTs (Boson, MultiG, Standard Q, and VivaDiag) had both sensitivity and specificity ≥98% to anti-SARS-CoV-2 IgG antibodies. Only three RDTs had a sensitivity ≥98%, while 10 RDTs had a specificity ≥98% to anti-SARS-CoV-2 IgM antibodies. Three RDTs (Autobio, MultiG, and Standard Q) had sensitivity and specificity ≥98% to combined IgG/IgM. The RDTs that performed well also had perfect or almost perfect inter-reader agreement. Conclusions: This evaluation identified three RDTs with a sensitivity and specificity to IgM/IgG antibodies of ≥98% with the potential for widespread antibody testing in Uganda.Tom LutaloAminah NalumansiDenis OlaraJohn KayiwaBernard OgwangEmmanuel OdwiloChristine WateraStephen BalinandiJocelyn KiconcoJoweria NakaseeguJennifer SerwangaBernard KikaireDeogratius SsemwangaBrendah AbikoChristopher NserekoMatthew CottenJoshua BuuleJulius LutwamaRobert DowningPontiano KaleebuElsevierarticleCOVID-19SARS-CoV-2Rapid diagnostic testantibodyserological reference panelperformanceInfectious and parasitic diseasesRC109-216ENInternational Journal of Infectious Diseases, Vol 112, Iss , Pp 281-287 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	COVID-19 SARS-CoV-2 Rapid diagnostic test antibody serological reference panel performance Infectious and parasitic diseases RC109-216
spellingShingle	COVID-19 SARS-CoV-2 Rapid diagnostic test antibody serological reference panel performance Infectious and parasitic diseases RC109-216 Tom Lutalo Aminah Nalumansi Denis Olara John Kayiwa Bernard Ogwang Emmanuel Odwilo Christine Watera Stephen Balinandi Jocelyn Kiconco Joweria Nakaseegu Jennifer Serwanga Bernard Kikaire Deogratius Ssemwanga Brendah Abiko Christopher Nsereko Matthew Cotten Joshua Buule Julius Lutwama Robert Downing Pontiano Kaleebu Evaluation of the performance of 25 SARS-CoV-2 serological rapid diagnostic tests using a reference panel of plasma specimens at the Uganda Virus Research Institute
description	Introduction: Serological testing is needed to better understand the epidemiology of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus. Rapid diagnostic tests (RDTs) have been developed to detect specific antibodies, IgM and IgG, to the virus. The performance of 25 of these RDTs was evaluated. Methods: A serological reference panel of 50 positive and 100 negative plasma specimens was developed from SARS-CoV-2 PCR and antibody positive patients and pre-pandemic SARS-CoV-2-negative specimens collected in 2016. Test performance of the 25 RDTs was evaluated against this panel. Results: A total of 10 RDTs had a sensitivity ≥98%, while 13 RDTs had a specificity ≥98% to anti-SARS-CoV-2 IgG antibodies. Four RDTs (Boson, MultiG, Standard Q, and VivaDiag) had both sensitivity and specificity ≥98% to anti-SARS-CoV-2 IgG antibodies. Only three RDTs had a sensitivity ≥98%, while 10 RDTs had a specificity ≥98% to anti-SARS-CoV-2 IgM antibodies. Three RDTs (Autobio, MultiG, and Standard Q) had sensitivity and specificity ≥98% to combined IgG/IgM. The RDTs that performed well also had perfect or almost perfect inter-reader agreement. Conclusions: This evaluation identified three RDTs with a sensitivity and specificity to IgM/IgG antibodies of ≥98% with the potential for widespread antibody testing in Uganda.
format	article
author	Tom Lutalo Aminah Nalumansi Denis Olara John Kayiwa Bernard Ogwang Emmanuel Odwilo Christine Watera Stephen Balinandi Jocelyn Kiconco Joweria Nakaseegu Jennifer Serwanga Bernard Kikaire Deogratius Ssemwanga Brendah Abiko Christopher Nsereko Matthew Cotten Joshua Buule Julius Lutwama Robert Downing Pontiano Kaleebu
author_facet	Tom Lutalo Aminah Nalumansi Denis Olara John Kayiwa Bernard Ogwang Emmanuel Odwilo Christine Watera Stephen Balinandi Jocelyn Kiconco Joweria Nakaseegu Jennifer Serwanga Bernard Kikaire Deogratius Ssemwanga Brendah Abiko Christopher Nsereko Matthew Cotten Joshua Buule Julius Lutwama Robert Downing Pontiano Kaleebu
author_sort	Tom Lutalo
title	Evaluation of the performance of 25 SARS-CoV-2 serological rapid diagnostic tests using a reference panel of plasma specimens at the Uganda Virus Research Institute
title_short	Evaluation of the performance of 25 SARS-CoV-2 serological rapid diagnostic tests using a reference panel of plasma specimens at the Uganda Virus Research Institute
title_full	Evaluation of the performance of 25 SARS-CoV-2 serological rapid diagnostic tests using a reference panel of plasma specimens at the Uganda Virus Research Institute
title_fullStr	Evaluation of the performance of 25 SARS-CoV-2 serological rapid diagnostic tests using a reference panel of plasma specimens at the Uganda Virus Research Institute
title_full_unstemmed	Evaluation of the performance of 25 SARS-CoV-2 serological rapid diagnostic tests using a reference panel of plasma specimens at the Uganda Virus Research Institute
title_sort	evaluation of the performance of 25 sars-cov-2 serological rapid diagnostic tests using a reference panel of plasma specimens at the uganda virus research institute
publisher	Elsevier
publishDate	2021
url	https://doaj.org/article/0b0beca23d9d43df8d2c2299dac6f1d8
work_keys_str_mv	AT tomlutalo evaluationoftheperformanceof25sarscov2serologicalrapiddiagnostictestsusingareferencepanelofplasmaspecimensattheugandavirusresearchinstitute AT aminahnalumansi evaluationoftheperformanceof25sarscov2serologicalrapiddiagnostictestsusingareferencepanelofplasmaspecimensattheugandavirusresearchinstitute AT denisolara evaluationoftheperformanceof25sarscov2serologicalrapiddiagnostictestsusingareferencepanelofplasmaspecimensattheugandavirusresearchinstitute AT johnkayiwa evaluationoftheperformanceof25sarscov2serologicalrapiddiagnostictestsusingareferencepanelofplasmaspecimensattheugandavirusresearchinstitute AT bernardogwang evaluationoftheperformanceof25sarscov2serologicalrapiddiagnostictestsusingareferencepanelofplasmaspecimensattheugandavirusresearchinstitute AT emmanuelodwilo evaluationoftheperformanceof25sarscov2serologicalrapiddiagnostictestsusingareferencepanelofplasmaspecimensattheugandavirusresearchinstitute AT christinewatera evaluationoftheperformanceof25sarscov2serologicalrapiddiagnostictestsusingareferencepanelofplasmaspecimensattheugandavirusresearchinstitute AT stephenbalinandi evaluationoftheperformanceof25sarscov2serologicalrapiddiagnostictestsusingareferencepanelofplasmaspecimensattheugandavirusresearchinstitute AT jocelynkiconco evaluationoftheperformanceof25sarscov2serologicalrapiddiagnostictestsusingareferencepanelofplasmaspecimensattheugandavirusresearchinstitute AT jowerianakaseegu evaluationoftheperformanceof25sarscov2serologicalrapiddiagnostictestsusingareferencepanelofplasmaspecimensattheugandavirusresearchinstitute AT jenniferserwanga evaluationoftheperformanceof25sarscov2serologicalrapiddiagnostictestsusingareferencepanelofplasmaspecimensattheugandavirusresearchinstitute AT bernardkikaire evaluationoftheperformanceof25sarscov2serologicalrapiddiagnostictestsusingareferencepanelofplasmaspecimensattheugandavirusresearchinstitute AT deogratiusssemwanga evaluationoftheperformanceof25sarscov2serologicalrapiddiagnostictestsusingareferencepanelofplasmaspecimensattheugandavirusresearchinstitute AT brendahabiko evaluationoftheperformanceof25sarscov2serologicalrapiddiagnostictestsusingareferencepanelofplasmaspecimensattheugandavirusresearchinstitute AT christophernsereko evaluationoftheperformanceof25sarscov2serologicalrapiddiagnostictestsusingareferencepanelofplasmaspecimensattheugandavirusresearchinstitute AT matthewcotten evaluationoftheperformanceof25sarscov2serologicalrapiddiagnostictestsusingareferencepanelofplasmaspecimensattheugandavirusresearchinstitute AT joshuabuule evaluationoftheperformanceof25sarscov2serologicalrapiddiagnostictestsusingareferencepanelofplasmaspecimensattheugandavirusresearchinstitute AT juliuslutwama evaluationoftheperformanceof25sarscov2serologicalrapiddiagnostictestsusingareferencepanelofplasmaspecimensattheugandavirusresearchinstitute AT robertdowning evaluationoftheperformanceof25sarscov2serologicalrapiddiagnostictestsusingareferencepanelofplasmaspecimensattheugandavirusresearchinstitute AT pontianokaleebu evaluationoftheperformanceof25sarscov2serologicalrapiddiagnostictestsusingareferencepanelofplasmaspecimensattheugandavirusresearchinstitute
_version_	1718406785335820288

Evaluation of the performance of 25 SARS-CoV-2 serological rapid diagnostic tests using a reference panel of plasma specimens at the Uganda Virus Research Institute

Ejemplares similares